We are still involved in the SNSA consultations in 2026

At the same time, discussions are taking place at the international level regarding adjustments to the SNSA format in order to enable greater flexibility and efficiency. Once new conditions are clarified, the information on SNSA will be updated on the website of the HMA (Heads of Medicines Agencies). Until then, applications submitted to SÚKL may follow the current rules , with the possibility of expanding the scope of SNSA to include all types of scientific advice currently provided by the Marketing Authorisation Section (e.g, clinical trials, MRP/DCP procedures). If requested by the applicant, a written SNSA format is also possible.

For more detailed information regarding SÚKL’s involvement in SNSA, please contact konzultace.reg@sukl.gov.cz.